Literature DB >> 8709416

[Estimation of catecholamine release based on dialyzer clearance rate during hemodialysis].

K Yamaya1, Y Terayama, K Nigawara, T Funyu, J Takahashi, K Yosikawa, T Suzuki.   

Abstract

To estimate catecholamine (CA) release during hemodialysis (HD), plasma-free and conjugated CAs and their dialyzer clearance rates were measured in 10 HD patients (age; 49.8 +/- 15.2 years, duration of HD; 5.8 +/- 5.0 years). Although free dopamine (f-DA) and all conjugated CAs decreased to about one half of the pre-HD levels at the end of HD, no significant change was seen in free norepinephrine (f-NE) and epinephrine (f-E) during HD. For every CA, the clearance rate was the highest in the sulfate and the lowest in the glucuronide form, and NE was the highest in every form. In the comparison between the measured CA and calculated CA using the clearance rate and the pre-HD level, the measured values of f-NE and f-E were significantly higher than the calculated values, unlike the results for f-DA and conjugated CAs. The difference in f-NE between the measured and the calculated values correlated negatively with the change in mean blood pressure (delta MBP), and delta MBP was also correlated with the ultrafiltration volume. From these data, it was suggested that f-NE was released by the decrease of MBP due to the increase of ultra-filtration volume during HD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709416

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  1 in total

1.  Continuous Hemodiafiltration for Pheochromocytoma Crisis with a Positive Outcome.

Authors:  Go Koizumi; Ryo Saiki; Ippei Kurokawa; Kentaro Mikura; Tatsuya Iida; Norimitsu Murai; Mariko Kaji; Mai Hashizume; Yasuyoshi Kigawa; Kei Endo; Toru Iizaka; Fumiko Otsuka; Tomohide Isobe; Tomoko Norose; Nobuyuki Ohike; Jun Sasaki; Munetaka Hayashi; Haruaki Sasaki; Shoichiro Nagasaka
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.